Hereditary spherocytosis: A review of the clinical and molecular aspects of the disease

Blood Reviews

Volumn 10, Issue 3, 1996, Pages 129-147

  Hassoun, H ^a,b   Palek, J ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ANTIPORTER; ERYTHROCYTE BAND 4.2 PROTEIN; MEMBRANE PROTEIN; MUTANT PROTEIN; SPECTRIN;

ANIMAL MODEL; CLINICAL FEATURE; CYTOSKELETON; ERYTHROCYTE MEMBRANE; GENE MUTATION; HEREDITARY HEMOLYTIC ANEMIA; HEREDITARY SPHEROCYTOSIS; HETEROZYGOTE; HUMAN; INHERITANCE; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFECT; REVIEW; SPLENECTOMY;

EID: 0029825262     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(96)90021-1     Document Type: Article

References (128)

1. Bennett V, Gilligan DM. The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu Rev Cell Biol 1993; 9: 27.
2. Palek J. Hereditary elliptocytosis, spherocytosis and related disorders: consequences of a deficiency or a mutation of membrane skeletal proteins. Blood Rev 1987; 1: 147.
3. Palek J, Sahr KE. Mutations of the red blood cell membrane proteins: from clinical evaluations to detection of the underlying genetic defect. Blood 1992; 80: 308.
4. Shotton DM, Burke BE, Branton D. The molecular structure of human erythrocyte spectrin. Biophysical and electron microscopic studies. J Mol Biol 1979; 131: 303.
5. Liu SC, Windisch P, Kim S, Palek J. Oligomeric states of spectrin in normal erythrocyte membranes: biochemical and electron microscopic studies. Cell 1984; 37: 587.
6. Speicher DW, Marchesi VT. Erythrocyte spectrin is comprised of many homologous triple helical segments. Nature 1984; 311: 177.
7. Yan Y, Winograd E, Viel T, Cronin T, Harrison SC, Branton D. Crystal structure of the repetitive segments of spectrin. Science 1993; 262: 2027.
8. Speicher DW, Weglarz L, DeSilva TM. Properties of human red cell spectrin heterodimer (side-to-side) assembly and identification of an essential nucleation site. J Biol Chem 1992; 267: 14775.
9. Morrow JS, Marchesi VT. Self-assembly of spectrin oligomers in vitro: a basis for a dynamic cytoskeleton. J Cell Biol 1981; 88: 463.
10. Speicher DW, DeSilva TM, Speicher KD, Ursitti JA, Hembach P, Weglarz L. Location of human red cell spectrin tetramer binding site and detection of a related "closed" hairpin loop dimer using proteolytic footprinting. J Biol Chem 1993; 268: 4227.
11. Cohen CM, Tyler JM, Branton D. Spectrin-actin associations studied by electron microscopy of shadowed preparations. Cell 1980; 21: 875.
12. McGough AM, Josephs R. On the structure of erythrocyte spectrin in partially expanded membrane skeletons. Proc Natl Acad Sci USA 1990; 87: 5208.
13. Becker PS, Schwartz MA, Morrow JS, Lux SE. Radiolabel-transfer cross-linking demonstrates that protein 4.1 binds to the N-terminal region of β spectrin and to actin in binary interactions. Eur J Biochem 1990; 193: 827.
14. Kennedy SP, Warren SL, Forget BG, Morrow JS. Ankyrin binds to the 15th repetitive unit of erythroid and nonerythroid β-spectrin. J Cell Biol 1991; 115: 267.
15. Lux SE, John KM, Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell cycle control proteins. Nature 1990; 344: 36.
16. Lambert S, Yu H, Prchal JT et al. cDNA sequence for human erythrocyte ankyrin. Proc Natl Acad Sci USA 1990; 87: 1730.
17. Peters LL, Lux SE. Ankyrins: structure and function in normal cells and hereditary spherocytes. Semin Hematol 1993; 30: 85.
18. Michaely P, Bennett V. The ANK repeats of erythrocyte ankyrin form two distinct cooperative binding sites for the erythrocyte anion exchanger. J Biol Chem 1995; 270: 22050.
19. +-ATPase. J Biol Chem 1995; 270: 29971.
20. Platt OS, Lux SE, Falcone JF. A highly conserved region of human erythrocyte ankyrin contains the capacity to bind spectrin. J Biol Chem 1993; 268: 24421.
21. Hall TG, Bennett V. Regulatory domains of erythrocyte ankyrin. J Biol Chem 1987; 262: 10537.
22. Tanner MJA. Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol 1993; 30: 34.
23. Low PS. Structure and function of the cytoplasmic domain of band 3: center of erythrocyte membrane-peripheral protein interactions. Biochim Biophys Acta 1986; 864: 145.
24. Lux SE, John KM, Kopito RR, Lodish HF. Cloning and characterization of band 3, the human erythrocyte anion exchange protein (AE1). Proc Natl Acad Sci USA 1989; 86: 9089.
25. Tanner MJA, Martin PG, High S. The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA. Biochem J 1988; 256: 703.
26. Kliman HJ, Steck TL. Association of glyceraldehyde-3-phosphate dehydrogenase with the human red cell membrane. J Biol Chem 1980; 255: 6314.
27. Tsai I, Prasanna Murthy SN, Steck TL. Effect of red cell membrane binding on the catalytic activity of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1982; 257: 1438.
28. Yu J, Steck TL. Associations of band 3, the predominant polypeptide of the human erythrocyte membrane. J Biol Chem 1975; 250: 9176.
29. Waugh SM, Walder JA, Low PS. Partial characterization of the copolymerization reaction of erythrocyte membrane band 3 with hemichromes. Biochemistry 1987; 26: 1777.
30. Kannan R, Labotka R, Low PS. Isolation and characterization of the hemichrome-stabilized membrane protein aggregates from sickle erythrocytes. J Biol Chem 1988; 263: 13766.
31. McPherson RA, Sawyer WH, Tilley L. Rotational diffusion of the erythrocyte integral membrane protein band 3: effect of hemichrome binding. Biochemistry 1992; 31: 512.
32. Bennett V, Stenbuck PJ. The membrane attachment protein for spectrin is associated with band 3 in human erythrocyte membranes. Nature 1979; 280: 468.
33. Davis L, Lux SE, Bennett V. Mapping the ankyrin-binding site on the human erythrocyte anion exchanger. J Biol Chem 1989; 264: 9665.
34. Hargreaves WR, Giedd KN, Verkleij A, Branton D. Reassociation of ankyrin with band 3 in erythrocyte membranes and in lipid vesicles. J Biol Chem 1980; 255: 11965.
35. Thevenin BJM, Low PS. Kinetics and regulation of the ankyrin-band 3 interactions of the human red blood cell membrane. J Biol Chem 1990; 265: 16166.
36. Jennings ML. Structure and function of the red blood cell anion transport protein. Annu Rev Biophys Chem 1989; 18: 397.
37. Liu S-C, Palek J, Yi SJ et al. Molecular basis of altered red blood cell membrane properties in SAO: role of the mutant band 3 protein in band 3 oligomerization and retention by the membrane skeleton. Blood 1995; 86: 349.
38. Hanspal M, Hanspal JS, Yi SJ, Liu SC, Palek J. Oligomerization of band 3 and its association with ankyrin during terminal maturation of friend virus infected mouse erythroblasts. Blood 1994; 84: 5a.
39. Cohen CM, Dotimas L, Korsgren C. Human erythrocyte membrane protein band 4.2 (pallidin). Semin Hematol 1993; 30: 19.
40. Yawata Y. Red cell membrane protein 4.2: phenotypic, genetic and electron microscopic aspects. Biochem Biophys Acta 1994; 1204: 131.
41. Korsgren C, Cohen CM. Organization of the gene for human erythrocyte membrane protein 4.2 structural similarities with the gene for the subunit of factor XIII. Proc Natl Acad Sci USA 1991; 88: 4840.
42. Korsgren C, Lawler J, Lambert S, Speicher D, Cohen CM. Complete amino acid sequence and homologies of human erythrocyte membrane protein band 4.2. Proc Natl Acad Sci USA 1990; 87: 613.
43. Hanspal M, Palek J. Biogenesis of normal and abnormal red blood cell membrane skeleton. Semin Hematol 1992; 29: 305.
44. Peters LL, Shivdasani RA, Liu S et al. Targeted disruption of the band 3 gene in mice causes severe hemolytic anemia despite a nearly normal membrane skeleton assembly. Blood 1995; 86: 124a.
45. Godal HC, Heist H. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand J Haematol 1981; 27: 30.
46. Eber SW, Pekrun A, Neufeldt A, Schroter W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors - screening using a modified glycerol lysis test. Ann Hematol 1992; 64: 88.
47. Eber SW, Armbrust R, Schroter W. Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility and autohemolysis. J Pediatr 1990; 177: 409.
48. Agre P, Asimos A, Casella JF, McMillan D. Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med 1986; 315: 1579.
49. Lux SE, Palek J. Disorders of the red cell membrane. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Philadelphia, PA: JB Lippincott, 1995: 1701.
50. Gehlback SH, Cooper BA. Hemolytic anemia in infectious mononucleosis due to inapparent congenital spherocytosis. Scand J Haematol 1970; 7: 141.
51. Pajor A, Lehoczky D, Szackacs Z. Pregnancy and hereditary spherocytosis: report of 8 patients and a review. Arch Gynecol Obstet 1993; 253: 37.
52. Godal HC, Refsum HE. Hemolysis in athletes due to hereditary spherocytosis. Scand J Haematol 1979; 22: 83.
53. Friedman EW, Williams JC, Van Hook L. Hereditary spherocytosis in the elderly. Am J Med 1988; 84: 513.
54. Schroter W, Kahsnitz E. Diagnosis of hereditary spherocytosis in newborn infants. J Pediatr 1983; 103: 460.
55. Agre P, Orringer EP, Bennett V. Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med 1982; 306: 1155.
56. Diamond LK. Indication for splenectomy in childhood: results in 52 operated cases. Am J Surg 1938; 39: 400.
57. Bates GC, Brown CH. Incidence of gallbladder disease in chronic hemolytic anemia (spherocytosis). Gastroenterology 195; 21: 104.
58. MacKinney AA, Morton NE, Kosower NS, Schilling RF. Ascertaining genetic carriers of hereditary spherocytosis by statistical analysis of multiple laboratory tests. J Clin Invest 1962; 41: 554.
59. Becker PS, Tse WT, Lux SE, Forget BG: β-Spectrin Kissimmee - a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1. J Clin Invest 1993; 92: 612.
60. Hassoun H, Vassiliadis JN, Murray J et al. Molecular basis of spectrin deficiency in β-spectrin Durham: a deletion within β-spectrin adjacent to the ankyrin-binding site precludes spectrin attachement to the membrane in hereditary spherocytosis. J Clin Invest 1995; 96: 2623.
61. Streichman S, Gesheidt Y, Tatarsky I. Hypertonic cryohemolysis: a diagnostic test for hereditary spherocytosis. Am J Hematol 1990; 35: 104.
62. Clark MR, Mohandas N, Shohet SB. Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood 1983; 61: 899.
63. Chapman RG. Red cell life span after splenectomy in hereditary spherocytosis. J Clin Invest 1968; 47: 2263.
64. Palek J, Jarolim P. Hereditary spherocytosis. In: Williams WJ, Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Hematology. New York: McGraw Hill, 1995: 536-557.
65. Croom RDI, McMillan CW, Sheldon GF, Orringer EP. Hereditary spherocytosis: recent experience and current concepts of pathophysiology. Ann Surg 1986; 203: 34.
66. Lux SE. Disorders of the red cell membrane. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood. Philadelphia, PA: WB Saunders, 1987: 489-490.
67. Schilling RF. Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann Intern Med 1995; 122: 187.
68. Rutkow IM. Twenty years of splenectomy for hereditary spherocytosis. Arch Surg 1981; 116: 306.
69. Facon T, Caulier MT, Fenaux P et al. Accessory spleen in recurrent chronic immune thrombocytopenic purpura. Am J Hematol 1992; 41: 184.
70. Dacie J, ed. The Haemolytic Anaemias. Edinburgh: Churchill Livingstone, 1985.
71. Tchernia G, Gautheir F, Mielot F et al. Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis. Blood 1993; 81: 2014.
72. Israel DM, Hassal E, Culham GJA, Phillips RR. Partial splenic embolization in children with hypersplenism. J Pediatr 1994; 124: 95.
73. Winkelmann JC, Forget BG. Erythroid and nonerythroid spectrins. Blood 1993; 81: 3173.
74. Moon RT, Ngai J, Wold BJ, Lazarides E. Tissue-specific expression of distinct spectrin and ankyrin transcripts in erythroid and nonerythroid cells. J Cell Biol 1985; 100: 152.
75. Nelson WJ, Lazarides E. Globin (ankyrin) in striated muscle: identification of the potential membrane receptor for erythroid spectrin in muscle cells. Proc Natl Acad Sci USA 1984; 81: 3292.
76. Peters LL, Birkenmeier CS, Bronson RT et al. Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J Cell Biol 1991; 114: 1233.
77. Kordeli E, Bennett V. Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice. J Cell Biol 1991; 114: 1243.
78. Brosius FC, Alper SL, Garcia AM, Lodish HF. The major kidney band 3 transcript predicts an amino-terminal truncated band 3 polypeptide. J Biol Chem 1989; 264: 7784.
79. Kudrycki KE, Schull GE. Primary structure of the rat kidney band 3 anion exchange protein deduced from a cDNA. J Biol Chem 1989; 264: 8185.
80. White RA, Peters LL, Adkison LR, Korsgren C, Cohen CM, Lux SE. The murine pallid mutation is a platelet storage pool disease associated with the protein 4.2 (pallidin) gene. Nature Genet 1992; 2: 80.
81. Lux SE, Tse WT, Menninger JC et al. Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature 1990; 345: 736.
82. McCann SR, Jacob HS. Spinal cord disease in hereditary spherocytosis: report of two cases with hypothesized common mechanism for neurologic and red cell abnormalities. Blood 1976; 48: 259.
83. Spencer SE, Walker FO, Moore SA. Chorea-amyotrophy with chronic hemolytic anemia: a variant of choreaamyotrophy with acanthocytosis. Neurology 1987; 37: 645.
84. Chilcote RR, LeBeau MM, Damier C et al. Association of red cell spherocytosis with deletion of the short arm of chromosome 8. Blood 1987; 69: 156.
85. Cohen H, Walker H, Delhanty DA, Lucas SB, Huehns ER. Congenital spherocytosis, B19 parvovirus infection and inherited interstitial deletion of the short arm of chromosome 8. Br J Haematol 1991; 78: 251.
86. Kitatani M, Chiyo H, Ozaki M, Shike S, Miwa S. Localization of the spherocytosis gene to chromosome segment 8p 11.22-8p 21.1. Hum Genet 1988; 78: 94.
87. Hanspal M, Hanspal J, Kalraiya R. Asynchronous synthesis of membrane skeletal proteins during terminal maturation of murine erythroblasts. Blood 1992; 80: 530.
88. Moon RT, Lazarides E. β-Spectrin limits α-spectrin assembly on membranes following synthesis in a chicken erythroid cell lysate. Nature 1983; 305: 62.
89. Marchesi SL, Agre PA, Speicher DW, Tse WT, Forget BG. Mutant spectrin aII domain in recessively inherited spherocytosis. Blood 1989; 74 (suppl 1): 182a.
90. Wichterle H, Palek J, Hanspal M, Smockova Y, Brabec V, Jarolim P. Two recessively inherited defects of α spectrin underlie a severe spectrin deficient spherocytic hemolytic anemia. Blood 1995; 86: 468a.
91. Wolfe LC, John KM, Falcone JC, Byrne AM, Lux SE. A genetic defect in binding of protein 4.1 to spectrin in a kindred with hereditary spherocytosis. N Engl J Med 1982; 307: 1367.
92. Hassoun H, Murray J, Vassiliadis JN, Hanspal M, Johnson CA, Palek J. Hereditary spherocytosis with spectrin deficiency due to an unstable truncated β spectrin: spectrin Winston-Salem. Blood 1995; 86: 467a.
93. Hassoun H, Vassiliadis JN, Murray J et al. Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency. Blood 1995; 86: 467a.
94. Hanspal M, Yoon S, Yu H et al. Molecular basis of spectrin and ankyrin deficiencies in severe hereditary spherocytosis: evidence implicating a primary defect of ankyrin. Blood 1991; 77: 165.
95. Coetzer TL, Lawler J, Liu SC. Partial ankyrin and spectrin deficiency in severe, atypical hereditary spherocytosis. N Engl J Med 1988; 318: 230.
96. Costa FF, Agre P, Watkins PC et al. Linkage of dominant hereditary spherocytosis to the gene for the erythrocyte membrane-skeleton protein ankyrin. N Engl J Med 1990; 323: 1046.
97. Savvides P, Shalev O, John KM, Lux SE. Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood 1993; 82: 2953.
98. Jarolim P, Brabec V, Lambert S et al. Ankyrin Prague: a dominantly inherited mutation of the regulatory domain of ankyrin associated with hereditary spherocytosis. Blood 1990; 76(suppl 1): 37a.
99. RAKOVNIK). Blood 1993; 82 (suppl. 1): 5a.
100. Eber SW, Lux ML, Gonzalez JM et al. Discovery of 8 ankyrin mutations in hereditary spherocytosis (HS) indicates that ankyrin defects are a major cause of dominant and recessive HS. Blood 1993; 82 (suppl 1): 3089.
101. Eber SW, Gonzalez JM, Lux ML et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet 1996; 13: 214-218.
102. n microsatellites in genomic DNA and mRNA reveals absence of one ankyrin mRNA allele in 20% of patients with hereditary spherocytosis. Blood 1995; 85: 3278.
103. Jarolim P, Rubin HL, Brabec V, Palek J. Clustered arginine substitutions in the membrane domain of erythroid band 3 protein in hereditary spherocytosis with band 3 deficiency. Blood 1993; 82 (suppl. 1): 3089.
104. Prchal JT, Guan Y, Jarolim P, Palek J, Showe L, Bertoli L. Hereditary spherocytosis in a large family is linked with the band 3 gene and not with α-spectrin, β-spectrin or ankyrin. Blood 1991; 78 (suppl 1): 81a.
105. PRAGUE). J Clin Invest 1994; 93: 121.
106. Jarolim P, Rubin HL, Brabec V et al. Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis. Blood 1995; 85: 634.
107. Montefiore). Blood 1993; 81: 2155.
108. 327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2. Blood 1991; 78 (Suppl 1): 252a.
109. NIPPON). Blood 1992; 79: 1846.
110. FUKUOKA). Br J Haematol 1994; 88: 527.
111. Bloom ML, Kaysser TM, Birkenmeier CS, Barker JE. The murine mutation jaundiced is caused by replacement of an arginine with a stop codon in the mRNA encoding the ninth repeat of β spectrin. Proc Natl Acad Sci USA 1994; 91: 10099.
112. Bodine DM, Birkenmeier CS, Barker JE. Spectrin deficient inherited hemolytic anemias in the mouse: characterization by spectrin synthesis and mRNA activity in reticulocytes. Cell 1984; 37: 721.
113. Yawata Y, Inaba M, Yawata A et al. Complete band 3 deficiency in cattle: a model for hereditary spherocytosis with striking instability of cytoskeletal network with marked exoand endocytosis. Blood 1995; 86: 468a.
114. Reed CF, Swisher SN. Erythrocyte lipid loss in hereditary spherocytosis. J Clin Invest 1966; 45: 777.
115. Cooper RA, Jandl JH. The selective and conjoint loss of red cell lipids. J Clin Invest 1969; 48: 906.
116. Liu SC, Derick L, Duquette MA, Palek J. Separation of the lipid bilayer from the membrane skeleton during discocyte-echinocyte transformation of human erythrocyte ghosts. Eur J Cell Biol 1989; 49: 358.
117. Hassoun H, Vassiliadis JN, Murray J, Jarolim P, Brabec V, Palek J. β spectrin Tabor: a nonsense mutation within the β spectrin gene associated with dominantly inherited spherocytosis and spectrin deficiency. Blood 1994; 84: 6a.
118. Hassoun H, Vassiliadis JN, Murray J et al. A deletion within the β spectrin gene associated with a truncated protein and resulting in hereditary spherocytosis: β spectrin Durham. Blood 1994; 84: 4a.
119. Morle L, Miraglia del Giudice E, Bozon M et al. Apparently recessive hereditary spherocytosis associated with de novo frameshift mutations of the ankyrin gene (Ank1): allele Bugey and allele Napoli. Blood 1996; 86: 467a.
120. Jarolim P, Murray J, Rubin HL, Palek J. Molecular characterization of hereditary spherocytosis with band 3 deficiency. Blood 1994; 84: 362a.
121. Bianchi P, Zanella A, Alloisio N et al. Band 3 Milano: a large (69) duplication of the erythrocyte band 3 gene associated with dominant hereditary spherocytosis. Blood 1995; 86: 468a.
122. Miraglia del Giudice E, Alloisio N, Vallier A et al. Band 3 Foggia and band 3 Napoli: frameshift mutations causing hereditary spherocytosis with band 3 deficiency. Blood 1995; 86: 631a.
123. Gallagher PG, Abou-Alfa GK, Floyd P et al. Band 3 Noirterre: a nonsense mutation of the erythroid band 3 gene causing dominant hereditary spherocytosis. Blood 1994; 84: 6a.
124. Maillet P, Vallier A, Reinhart WH et al. Band 3 Chur: a variant associated with band 3 deficient hereditary spherocytosis and substitution in a highly conserved position of transmembrane segment 11. Br J Haematol 1995; 91: 804.
125. 327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2. Blood 1992; 80: 523.
126. Notame). Hum Mol Genet 1995; 4: 1187.
127. Hayette S, Dhermy D, dos Santos M-E et al. A deletional frameshift mutation in protein 4.2 gene (allele 4.2 Lisboa) associated with hereditary hemolytic anemia. Blood 1995; 85: 250.
128. Kanzaki A, Yasunaga M, Okamoto N et al. Band 4.2 Shiga: 317 CGC → TGC in compound heterozygotes with 142 GCT → ACT results in band 4.2 deficiency and microspherocytosis. Br J Haematol 1995; 91: 333.